For investors
Discover high-potential startup deals. Support those you believe in with expert guidance from seasoned investors.
Curated deal flow
We carefully screen between 1000 and 2500 early-stage startups every year to bring you the best, high-potential investment opportunities.
Expert Due Diligence
The pre-screened investment opportunities we present undergo a structured due diligence process led by experienced deal leaders.
Investment syndication
Diversify your portfolio by pooling your resources with a group of likeminded investors within a streamlined funding process.
Deal Leader program
Get the training to become a certified deal leader. Enjoy industry exposure and the opportunity to earn money on successful deals.
Education & training
Access a comprehensive range of courses delivered by expert investors. Learn about best practices and stay up to date with market intelligence.
Diverse investor community
Join a global community of early-stage investors from 41 countries spread across five continents, representing 51 nationalities.
Global reach
We source investment opportunities from juried shows, competitions and networks across select European markets and the US.
High-tech platform
View startups pitches, ask questions, invest and manage your deals through our virtual platform where you’ll also find our knowledge centre.
How to invest
Choose a method that best reflects how much you want to invest and how involved you want to get in decisions, mentoring and training.
Individual Portfolio Investing
Handpick which startups to invest in
Climate Action
Addressing climate change by supporting the transition to carbon neutrality
Gender Lens
Empowering women participation in angel investing through a global community of successful female professionals
All Tech
Support startups at the forefront of innovation.
Successfully funded startups
Flyability
Building commercial drones for the industrial inspection of indoor, confined and complex spaces
Technology Switzerland
OtoSense
Sound recognition software platform allowing its clients to turn non-speech sounds into actionable meaning
Technology United States
Cellestia Biotech AG
Oncology drug development company with focus on NOTCH pathway
Healthcare Switzerland
Subscribe to our newsletter
Here’s where we share insights and keep you posted about upcoming events.